Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02632201
What this trial is testing

Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis

Who this might be right for
Liver MetastasisGastric Cancer
Second Military Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00773695
What this trial is testing

Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 150
Not applicableStudy completedNCT05990582
What this trial is testing

The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years

Who this might be right for
Preterm BirthDevelopmental DelayGrowth Delay
Noordwest Ziekenhuisgroep 153
Testing effectiveness (Phase 2)Study completedNCT00217672
What this trial is testing

Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Oncology Research International 76
Not applicableStudy completedNCT01106781
What this trial is testing

A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 591
Not applicableStudy completedNCT03761901
What this trial is testing

Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 141
Large-scale testing (Phase 3)Looking for participantsNCT06058377
What this trial is testing

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2-Negative Breast Carcinoma+1 more
National Cancer Institute (NCI) 3,680
Not applicableWithdrawnNCT00999557
What this trial is testing

Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants

Who this might be right for
AlopeciaBreast Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Testing effectiveness (Phase 2)Study completedNCT02069093
What this trial is testing

Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 92
Not applicableUnknownNCT02629926
What this trial is testing

Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors

Who this might be right for
Metabolic DiseasesCancer
The Leeds Teaching Hospitals NHS Trust 60
Testing effectiveness (Phase 2)Looking for participantsNCT05987826
What this trial is testing

Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital 40
Not applicableLooking for participantsNCT07201376
What this trial is testing

Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically

Who this might be right for
Non-Melanoma Skin Cancer (NMSC)Benign Skin Growth
Dartmouth-Hitchcock Medical Center 125
Post-approval studies (Phase 4)Study completedNCT04776889
What this trial is testing

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic
National Cancer Institute, Egypt 70
Not applicableUnknownNCT01368133
What this trial is testing

The Observational Study of Growth Hormone-secreting Pituitary Tumors

Who this might be right for
AcromegalyPituitary Tumor
Huashan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00630552
What this trial is testing

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer
NantCell, Inc. 138
Testing effectiveness (Phase 2)Ended earlyNCT02495233
What this trial is testing

ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI)

Who this might be right for
Non-Small-Cell Lung Cancer
Astellas Pharma Global Development, Inc. 10
Large-scale testing (Phase 3)Study completedNCT01572038
What this trial is testing

Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 1,436
Large-scale testing (Phase 3)Study completedNCT03084939
What this trial is testing

Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 351
Testing effectiveness (Phase 2)Study completedNCT01204957
What this trial is testing

Brown Seaweed as a Breast Cancer Preventive

Who this might be right for
Breast Cancer
University of South Carolina 33
Next Page